BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19582876)

  • 1. Reduced expression and homozygous deletion of annexin A10 in gastric carcinoma.
    Kim J; Kim MA; Jee CD; Jung EJ; Kim WH
    Int J Cancer; 2009 Oct; 125(8):1842-50. PubMed ID: 19582876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of annexin A10 in gastric cancer and its overexpression in tumor cell growth suppression.
    Kim JK; Kim PJ; Jung KH; Noh JH; Eun JW; Bae HJ; Xie HJ; Shan JM; Ping WY; Park WS; Lee JY; Nam SW
    Oncol Rep; 2010 Sep; 24(3):607-12. PubMed ID: 20664964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krüppel-like factor 12 plays a significant role in poorly differentiated gastric cancer progression.
    Nakamura Y; Migita T; Hosoda F; Okada N; Gotoh M; Arai Y; Fukushima M; Ohki M; Miyata S; Takeuchi K; Imoto I; Katai H; Yamaguchi T; Inazawa J; Hirohashi S; Ishikawa Y; Shibata T
    Int J Cancer; 2009 Oct; 125(8):1859-67. PubMed ID: 19588488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative genomics identifies RAB23 as an invasion mediator gene in diffuse-type gastric cancer.
    Hou Q; Wu YH; Grabsch H; Zhu Y; Leong SH; Ganesan K; Cross D; Tan LK; Tao J; Gopalakrishnan V; Tang BL; Kon OL; Tan P
    Cancer Res; 2008 Jun; 68(12):4623-30. PubMed ID: 18559507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of leucine-rich-repeat-containing G-protein-coupled receptor 5, an intestinal stem cell marker, in gastric carcinomas.
    Jang BG; Lee BL; Kim WH
    Gastric Cancer; 2016 Jul; 19(3):767-77. PubMed ID: 26386561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of L1CAM is associated with tumor progression and prognosis via ERK signaling in gastric cancer.
    Ito T; Yamada S; Tanaka C; Ito S; Murai T; Kobayashi D; Fujii T; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Kodera Y
    Ann Surg Oncol; 2014 Feb; 21(2):560-8. PubMed ID: 24046108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulated SPARCL1 is associated with clinical significance in human gastric cancer.
    Li P; Qian J; Yu G; Chen Y; Liu K; Li J; Wang J
    J Surg Oncol; 2012 Jan; 105(1):31-7. PubMed ID: 22161898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
    Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
    Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and validation of Kallikrein-ralated peptidase 11 as a novel prognostic marker of gastric cancer based on immunohistochemistry.
    Wen YG; Wang Q; Zhou CZ; Yan DW; Qiu GQ; Yang C; Tang HM; Peng ZH
    J Surg Oncol; 2011 Oct; 104(5):516-24. PubMed ID: 21618246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulation of methylthioadenosin phosphorylase by homozygous deletion in gastric carcinoma.
    Kim J; Kim MA; Min SY; Jee CD; Lee HE; Kim WH
    Genes Chromosomes Cancer; 2011 Jun; 50(6):421-33. PubMed ID: 21412930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A10 Expression as a Novel Prognostic Marker in Lung Adenocarcinoma.
    Yumura M; Nagano T; Jimbo N; Dokuni R; Kiriu T; Tanaka Y; Tachihara M; Itoh T; Maniwa Y; Nishimura Y; Kobayashi K
    Anticancer Res; 2022 Mar; 42(3):1289-1294. PubMed ID: 35220218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Annexin A10 is an immunohistochemical marker for adenocarcinoma of the upper gastrointestinal tract and pancreatobiliary system.
    Lu SH; Yuan RH; Chen YL; Hsu HC; Jeng YM
    Histopathology; 2013 Nov; 63(5):640-8. PubMed ID: 24024557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and prognostic significance of gastric-specific annexin A10 in diffuse- and intestinal-type gastric carcinoma.
    Lu SH; Chen YL; Shun CT; Lai JN; Peng SY; Lai PL; Hsu HC
    J Gastroenterol Hepatol; 2011 Jan; 26(1):90-7. PubMed ID: 21175800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and clinical significance of long non-coding RNA HNF1A-AS1 in human gastric cancer.
    Dang Y; Lan F; Ouyang X; Wang K; Lin Y; Yu Y; Wang L; Wang Y; Huang Q
    World J Surg Oncol; 2015 Oct; 13():302. PubMed ID: 26472090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity at chromosomes 1p35-pter, 4q, and 18q and protein expression differences between adenocarcinomas of the distal stomach and gastric cardia.
    Xu Y; Man X; Lv Z; Li D; Sun Z; Chen H; Wang Z; Luo Y; Xu H
    Hum Pathol; 2012 Dec; 43(12):2308-17. PubMed ID: 22901464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptomic Analysis of Annexin A10 and Chemosensitivity in Gastric Adenocarcinoma Cells.
    Ishikawa A; Kuraoka K; Zaitsu J; Saito A; Kuwai T; Tazawa H; Suzuki T; Tashiro H; Taniyama K; Yasui W
    Anticancer Res; 2022 Apr; 42(4):1707-1717. PubMed ID: 35346989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. JAM-A expression positively correlates with poor prognosis in breast cancer patients.
    McSherry EA; McGee SF; Jirstrom K; Doyle EM; Brennan DJ; Landberg G; Dervan PA; Hopkins AM; Gallagher WM
    Int J Cancer; 2009 Sep; 125(6):1343-51. PubMed ID: 19533747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation.
    Liu SH; Lin CY; Peng SY; Jeng YM; Pan HW; Lai PL; Liu CL; Hsu HC
    Am J Pathol; 2002 May; 160(5):1831-7. PubMed ID: 12000734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of annexin A8 in the properties of pancreatic cancer.
    Hata H; Tatemichi M; Nakadate T
    Mol Carcinog; 2014 Mar; 53(3):181-91. PubMed ID: 23001853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.